Vaxil Bio (TSXV:VXL) Total Assets : C$0.98 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Total Assets?

Vaxil Bio's Total Assets for the quarter that ended in Dec. 2023 was C$0.98 Mil.

During the past 12 months, Vaxil Bio's average Total Assets Growth Rate was 22.60% per year. During the past 3 years, the average Total Assets Growth Rate was -36.90% per year. During the past 5 years, the average Total Assets Growth Rate was -28.50% per year. During the past 10 years, the average Total Assets Growth Rate was -9.60% per year.

During the past 13 years, Vaxil Bio's highest 3-Year average Total Assets Growth Rate was 224.80%. The lowest was -77.50%. And the median was -13.50%.

Total Assets is connected with ROA %. Vaxil Bio's annualized ROA % for the quarter that ended in Dec. 2023 was 10.27%. Total Assets is also linked to Revenue through Asset Turnover. Vaxil Bio's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Vaxil Bio Total Assets Historical Data

The historical data trend for Vaxil Bio's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Total Assets Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

0.21

1.66

2.29

1.54

0.98

Vaxil Bio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															1.54	1.36	1.12	1.05	0.98

Vaxil Bio Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Vaxil Bio's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	0.891	+	0.085
	=	0.98

Vaxil Bio's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	0.891	+	0.085
	=	0.98

Vaxil Bio (TSXV:VXL) Total Assets Explanation

Total Assets is connected with ROA %.

Vaxil Bio's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	0.104	/	( (1.05	+	0.976)	/ 2 )
	=	0.104	/	1.013
	=	10.27 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Vaxil Bio's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0	/	( (1.05	+	0.976)	/ 2 )
=	0	/	1.013
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Vaxil Bio Total Assets Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio (TSXV:VXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

VXLLF:USA

Address

C/O Kira Lynn, Bennet Jones LLP, 3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Executives

Gadi Levin

Director, Senior Officer

Vaxil Bio (TSXV:VXL) Headlines

No Headlines